Public Profile

Roivant Sciences

Roivant Sciences, a pioneering biopharmaceutical company headquartered in the United States, focuses on advancing innovative therapies to address unmet medical needs. Founded in 2014, Roivant has rapidly established itself within the biotechnology industry, particularly in the fields of drug development and commercialisation. The company is renowned for its unique approach to drug development, leveraging its extensive portfolio of subsidiaries, known as "Vants," which specialise in various therapeutic areas. Roivant's commitment to utilising technology and data analytics distinguishes it from traditional pharmaceutical companies, enabling faster and more efficient pathways to market. With a strong market position, Roivant has achieved significant milestones, including successful partnerships and the launch of several promising therapies. Its dedication to transforming healthcare continues to drive its growth and influence in the biopharmaceutical landscape.

DitchCarbon Score

How does Roivant Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Roivant Sciences's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Roivant Sciences's reported carbon emissions

Roivant Sciences, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or evaluate their climate commitments. However, the absence of data may indicate that the company is in the early stages of developing a comprehensive sustainability strategy. As the industry increasingly prioritises climate action, Roivant Sciences may consider establishing measurable targets and initiatives to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roivant Sciences's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Roivant Sciences is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Roivant Sciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Bangkok Dusit Medical Services

TH
Health Services
Updated 10 days ago

Genor Biopharma Holdings

CN
Health Services
Updated 10 days ago

Shenhua Pharmaceutical

CN
Health Services
Updated 10 days ago

Beltone Electronics Corporation LLC

US
Health Services
Updated 2 days ago

Bio-Tech Pharmacal Inc.

US
Health Services
Updated 10 days ago

Nature4science Inc

US
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers